View of The Reply to the Letter to the Editor Regarding: "The Autologous CaTeVac Dendritic Cell Vaccine in Patients with Melanoma: Final Results of the DENDRON-01 Study" | Voprosy onkologii

← The Reply to the Letter to the Editor Regarding: "The Autologous CaTeVac Dendritic Cell Vaccine in Patients with Melanoma: Final Results of the DENDRON-01 Study"